SEC Form 4 · accession 0000905148-26-003841
Core Scientific, Inc./tx · CORZ
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Eric Stanton Weiss
Director
Period of report
Aug 18, 2026
Accepted (ET)
Aug 20, 2026 · 4:13 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001839341
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Aug 18, 2026 | P | 7,000 | $19.194 | A | 259,262 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $18.785 to $19.595, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within such range.